CHMP issues positive opinion to expand Jardiance, Synjardy and Glyxambi
European labels for Jardiance, Synjardy and Glyxambi expanded to include pos...
2018-07-03
文传商讯
Boehringer Ingelheim and Lilly Announce an Academic Collaboration with
University of Oxford to assess effect of empagliflozin on heart and kidney d...
2018-04-17
文传商讯
Jardiance (empagliflozin) significantly reduced the risk of progressive
Jardiance® (empagliflozin) is the only SGLT2 inhibitor to demonstrate th...
2016-06-17
文传商讯
New study results show Trajenta® (linagliptin) reduces blood sugar
Renal safety profile was consistent with that demonstrated in previous trial...
2016-06-15
文传商讯
